Kodiform Therapeutics

Private

LondonHealthcare & Life Scienceshttps://kodiform.com

Last Round

Seed

Jun 11, 2024

Company Overview

Kodiform Therapeutics is a biotechnology company that develops small molecule drugs to target intrinsically disordered proteins for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverysmall molecule inhibitorsintrinsically disordered proteinsundruggable targetsintracellular antibodiesoncology therapeuticsprotein-protein interactionsbiotech spinoutcomputational drug designdrug discovery platformIDPiDAbfirst-in-class drugsvirtual screeningbiotech partnering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kodiform Therapeutics Comparables

Compare Kodiform Therapeutics with similar companies based on industry and business-model similarity.

Kodiform Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Nuage Therapeutics	86%
RIANA Therapeutics	79%
Ambagon Therapeutics	79%

View all Comparables

Kodiform Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 11, 2024

View all Funding Rounds

Kodiform Therapeutics Investors

Notable investors and investment history

Kodiform Therapeutics investors
Investor	Rounds
Oxford Science Enterprises	Seed
Oxford University Innovation	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 11, 2024
Led by Oxford Science Enterprises with participation from Oxford University Innovation.

View all signals

Kodiform Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Kodiform Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kodiform Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Year Founded2024

Last FundingJun 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?